about
Rare disease registries classification and characterization: a data mining approach.QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists.Predictive models, based on classification algorithms, for compounds potentially active as mitochondrial ATP-sensitive potassium channel openers.The Quality of Rare Disease Registries: Evaluation and Characterization.Prediction of hERG potassium channel affinity by the CODESSA approach.Development of classification models for identifying "true" P-glycoprotein (P-gp) inhibitors through inhibition, ATPase activation and monolayer efflux assays.Combining structure- and ligand-based approaches for studies of interactions between different conformations of the hERG K+ channel pore and known ligands.Effects of divalent metal ions on the alphaB-crystallin chaperone-like activity: spectroscopic evidence for a complex between copper(II) and protein.Characterization and classification of Rare Disease Registries by using exploratory data analyses.2,9-disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: synthesis, biochemical and molecular modelling studies.Molecular modelling of human CYP2D6 and molecular docking of a series of ajmalicine- and quinidine-like inhibitors.Binding free energy calculations of adenosine deaminase inhibitors.Prevalence Estimates of Rare Congenital Anomalies by Integrating Two Population-Based Registries in Tuscany, Italy.Annoyance Judgment and Measurements of Environmental Noise: A Focus on Italian Secondary Schools.Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptors.Quantitative structure-activity relationship models for predicting biological properties, developed by combining structure- and ligand-based approaches: an application to the human ether-a-go-go-related gene potassium channel inhibition.Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.QSAR studies on BK channel activators.A modeling study of alphaB-crystallin in complex with zinc for seeking of correlations between chaperone-like activity and exposure of hydrophobic surfaces.Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosusRecommendations for Improving the Quality of Rare Disease RegistriesIdentification of "toxicophoric" features for predicting drug-induced QT interval prolongationSex differences for major congenital heart defects in Down Syndrome: A population based studyThe Role of Polybrominated Diphenyl Ethers in Thyroid Carcinogenesis: Is It a Weak Hypothesis or a Hidden Reality? From Facts to New PerspectivesStructural perturbation of αB-crystallin by zinc and temperature related to its chaperone-like activityStructural modifications of benzanilide derivatives, effective potassium channel openers. XTemperature dependence of chaperone-like activity and oligomeric state of αB-crystallinBioisosterism, enantioselectivity, and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: Different binding modes to A1 adenosine receptorsEpidemiology of achondroplasia: A population-based study in EuropeBisphenols as Environmental Triggers of Thyroid Dysfunction: Clues and EvidenceRespiratory Symptoms in Relation to Living near a Crude Oil First Treatment Plant in Italy: A Cross-Sectional Study
P50
Q30891850-5DFD2C3A-C851-4586-B78F-FD5CBEE8FABCQ33281530-053B0D5A-C756-4C38-80B4-937AD482DA80Q33481422-A5AE9401-5DC9-4AD5-B5DE-C0DB9EAA39D1Q39902446-605E2708-CD31-4562-B457-27A590142485Q40326863-078B4A10-A183-4E79-AFB4-F131D30C6529Q42237885-49A6B84C-0603-4458-9D1B-C922F5F67B34Q43834061-37D6D1FF-A492-4DA3-8379-4465F0D46A18Q44900862-07ADBFAE-5A51-4D3F-8E02-E630B62008D8Q46225704-49CA2723-D046-4F55-A6DA-E8F391D2FAE9Q46502570-4852E539-57F1-4DA6-BDC6-A38D1B6B3221Q46696823-34029E66-3A30-4E73-8703-02B3E99CF4A1Q46867102-71F37F64-67AC-49A5-999E-C28CF12AA48FQ47767060-49788529-531F-430E-A2B8-BC8CAABDF60AQ48159564-B7E15ED7-6266-4D64-8024-167391717D77Q48401526-224C3AF3-266B-4059-BA06-00AF83E0E8B2Q51793487-D1D44717-6974-4FD6-A100-2F9CA9C895AEQ51849169-F583067A-40B0-4F00-B359-2333C002DEA8Q51862572-F80A2924-4EB0-4377-9D0D-247475C229CEQ54480847-87EA59D1-7CB8-44AA-8C01-9B16DE00B6ACQ56379013-60FEB16A-5315-4470-A8FF-451EFA627DD2Q56814712-883B0560-16D3-49B2-A3A0-584F2A3F38E1Q57100776-381F3D24-70E3-4E38-B6DC-052AEEE932C6Q57838204-7800D0DA-9DF8-4CED-B52A-D72E308C1272Q57838206-C896F80D-D155-40B1-81E3-A17865CAEAE0Q57838216-75253989-1A2F-4FFC-B4C2-A97D9B47697FQ57838221-E41EB171-FF7E-4E57-80A3-BF37B160644EQ57838225-394BE3D3-5A5F-4BDF-926D-78B97BB5152CQ57838233-092B144C-EBFA-414E-8A05-8C293A621B32Q91794041-40860CB8-C91A-4C28-B0BC-179557541A35Q91962085-07F916A3-96E5-47C6-B15D-13BBAB9AE05BQ93376498-35030231-9DFC-45EE-B18F-A61C99D7E9DF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alessio Coi
@ast
Alessio Coi
@en
Alessio Coi
@es
Alessio Coi
@nl
Alessio Coi
@sl
type
label
Alessio Coi
@ast
Alessio Coi
@en
Alessio Coi
@es
Alessio Coi
@nl
Alessio Coi
@sl
prefLabel
Alessio Coi
@ast
Alessio Coi
@en
Alessio Coi
@es
Alessio Coi
@nl
Alessio Coi
@sl
P1053
M-3455-2017
P106
P1153
8532552500
P2002
AlessioCoi
P21
P31
P3829
P496
0000-0002-9816-3144